II
MDGL icon

Inspire Investing’s Madrigal Pharmaceuticals MDGL Stock Holding History

Inspire Investing’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$612K Buy
+1,140
New +$584K 0.03% 923
2026
Q1 		– Sell
-2,256
Closed -$1.31M – 1143
2025
Q4 		$1.31M Buy
+2,256
New +$1.15M 0.12% 183
2023
Q3 		– Sell
-1,224
Closed -$283K – 855
2023
Q2 		$283K Buy
1,224
+62
+5% +$16.8K 0.03% 777
2023
Q1 		$281K Buy
+1,162
New +$317K 0.04% 408

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Inspire Investing's MDGL Position: Q2 2026 in Review

Inspire Investing opened a new position in Madrigal Pharmaceuticals (MDGL) in Q2 2026: 1,140 shares worth $612K. The stake represents 0.03% of the portfolio and ranks #923 among its holdings. This is a return to the name: Inspire Investing previously reported a position in MDGL as recently as Q4 2025.

Inspire Investing first reported a position in MDGL in Q1 2023 and has held it in 4 quarters since. The position peaked at $1.31M in Q4 2025. 413 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • Inspire Investing held 1,140 shares of Madrigal Pharmaceuticals worth $612K as of Q2 2026.
  • Madrigal Pharmaceuticals was a new Inspire Investing position in Q2 2026.
  • Madrigal Pharmaceuticals made up 0.03% of Inspire Investing's portfolio in Q2 2026, its #923 holding.
  • Inspire Investing first reported a position in Madrigal Pharmaceuticals in Q1 2023 and has held it in 4 quarters since.
  • Inspire Investing's Madrigal Pharmaceuticals position peaked at $1.31M in Q4 2025.
  • 413 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Inspire Investing's 13F filing for Q2 2026, filed 12 Aug 2026.